The 2021 MHSRS is Cancelled
The 2021 MHSRS has been cancelled due to concerns related to the high COVID-19 Delta variant rate
in the Orlando-Kissimmee area.
All registration and vendor fees will be refunded in their entirety.
It is up to the attendee/exhibitor to cancel any hotel reservations.
This should be done as soon as possible to avoid any charges.
Address additional questions to [email protected]
Thank you to all of the individuals who have worked so hard to organize this meeting. This includes the abstract submitters/presenters, abstract reviewers, session leads, and meeting organizers. We are all disappointed. This decision was made after considering multiple courses of action to include the recent rise/trending of COVID-19 Delta variant rates in the Orlando-Kissimmee area and existing federal and state guidelines.
More than 2,000 scientists registered for the 2021 MHSRS before cancellation. Let’s apply that momentum forward to continue to demonstrate the value of military medical research for our Warfighters and in guiding our nation’s recovery from this global pandemic. Looking forward to seeing all of you at the 2022 MHSRS!
Terry M. Rauch, Ph.D., M.P.H., M.B.A.
Director, Medical R&D
OASD(HA)
Expert Insights
Led by industry experts and leaders in the field, the symposium includes 1,900+ highly vetted sessions, plenaries, and posters on Warfighter Medical Readiness, Expeditionary Medicine, Warfighter Performance, and Return to Duty.
Invaluable Connections
The MHSRS provides a collaborative environment for nearly 3,000 military medical care providers with deployment experience, DoD scientists, academia, and industry to meet and exchange information on the unique medical needs of the Warfighter.
Critical Solutions
Experience the latest solutions on the market from more than 100 leading manufacturers and suppliers, as well as companies on the forefront of technology, that are committed to advancing and improving the unique medical needs of the Warfighter.
Partners
“MHSRS is a great way to hear about excellent science and the needs of the military community. I recommend it to anyone interested in doing business with the Department of Defense.”
– Dr. Andrea Loewendorf, CEO
ImmunoVation, LLC